Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 36.8263.14-3.4820.95965.63

What is the latest Core EBITDA Growth ratio of ORCHID PHARMA ?

The latest Core EBITDA Growth ratio of ORCHID PHARMA is 36.82 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202436.82
Mar202363.14
Mar2022-3.48
Mar202120.95
Mar2020965.63

How is Core EBITDA Growth of ORCHID PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 36.82
-41.69
Mar2023 63.14
Positive
Mar2022 -3.48
Negative
Mar2021 20.95
-97.83
Mar2020 965.63 -

Other Financial Ratios of ORCHID PHARMA


Compare Core EBITDA Growth ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹4,159.7 Cr -2.7% 5.6% -26.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,314.0 Cr -0.4% 5.7% 20.2% Stock Analytics
DIVIS LABORATORIES ₹162,809.0 Cr 1.7% 6.2% 52.9% Stock Analytics
CIPLA ₹124,627.0 Cr -0.7% 7% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,127.0 Cr -1.6% 1.5% 21.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,839.9 Cr -2.3% 2.5% -6% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-2.7%

5.6%

-26.9%

SENSEX

2%

4.1%

9.6%


You may also like the below Video Courses